These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6934708)

  • 21. In vitro activity of thienamycin.
    Tally FP; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1978 Sep; 14(3):436-8. PubMed ID: 708019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 24. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Thompson RL; Fisher KA; Wenzel RP
    Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
    Ahonkhai VI; Cherubin CE; Sierra MF; Bokkenheuser VD; Shulman MA; Mosenthal AC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):850-1. PubMed ID: 6459767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
    Tutlane VA; McCloskey RV; Trent JA
    Antimicrob Agents Chemother; 1981 Jul; 20(1):140-3. PubMed ID: 6269481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
    Digranes A; Dibb WL; Benonisen E
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
    Michael PR; Alford RH; McGee ZA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
    Cynamon MH; Granato PA
    Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Neisseria meningitidis and Neisseria gonorrhoeae isolates to N-formimidoyl thienamycin.
    Dudek EJ; Stephenson JD; Bohnhoff M; Lerner SA
    Antimicrob Agents Chemother; 1982 Nov; 22(5):926-9. PubMed ID: 6817708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
    Nasu M; Maskell JP; Williams RJ; Williams JD
    Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative in vitro study of thienamycin.
    Fainstein V; LeBlanc B; Weaver S; Bodey GP
    Infection; 1982 Jan; 10(1):50-2. PubMed ID: 7068233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
    Grimm H
    Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
    Norrby SR; Alestig K; Ferber F; Huber JL; Jones KH; Kahan FM; Meisinger MA; Rogers JD
    Antimicrob Agents Chemother; 1983 Feb; 23(2):293-9. PubMed ID: 6573156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Kundargi R
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.